WBP1LP5

Across TCGA pan-cancer cohorts, WBP1LP5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of WBP1LP5’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where WBP1LP5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types WBP1LP5 is over-expressed in tumor.

KIRC, KIRP, and PRAD are the cancer types where WBP1LP5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in WBP1LP5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.033	.011	4	view →
KIRP	All	All	+0.072	.013	3	view →
PRAD	All	All	+0.043	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

WBP1LP5–KIRC

Open the KIRC breakdown →